A comparative analysis of generics markets in five European countries
about
Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug ApprovalInfluence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years.Generic Medicine Pricing Policies in Europe: Current Status and Impact.Determinants of generic drug substitution in Switzerland.Analyzing generic and branded substitution patterns in the Netherlands using prescription dataSpecial challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway.Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical marketPhysicians' perception of generic and electronic prescribing: A descriptive study from JordanGreek Physicians' Perceptions on Generic Drugs in the Era of AusterityQuality circles for pharmacotherapy to modify general practitioners' prescribing behaviour for generic drugs.Analysis of French generic medicines retail market: why the use of generic medicines is limited.Knowledge, attitudes, and practices of community pharmacists on generic medicines in Qatar.Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests?Impact of generic substitution practice on care of diabetic patients.Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability.Perceptions and behaviors of patients and pharmacists towards generic drug substitution in Lebanon.Competition in off-patent drug markets: Issues, regulation and evidenceModelling pharmaceutical price changes in Germany: a function of competition and regulation
P2860
Q28552883-0744DDCC-2500-49A2-93B4-4D1FEBDE8ADAQ33321951-31628406-F50F-45D0-9289-C791DBFC52D7Q33664184-0BDA8D5A-D5D8-4732-A0F3-AC3B120FA7BDQ33804307-B8F4B45E-F1EF-443B-A951-DAD1693AF6AFQ33882893-635A49B0-1DB4-4CE6-9599-523A57F23732Q34494595-BF69E7BE-0412-4FE8-94F4-E368AEACFD20Q34529140-6AEDB19B-8AAE-477B-B5D7-9F8A3BCC8656Q35198487-12048971-20E0-4C82-9453-F5559712933BQ36109450-2F58E717-D3E0-4073-8296-2BB3CE07B108Q37880219-B1D14FE6-F75C-4E90-9905-8D927F045B86Q38237236-7382B18D-C93B-49EC-AFFF-82D729C4D097Q39249776-AE9ED144-22CE-43B1-9062-44688C75B5A7Q42406922-4EA89399-25CB-4054-955F-1D384E58E9E8Q43855810-BB660444-D06A-4902-ADE5-45DAC5187661Q45349937-C150C7EE-E888-4BA6-B74B-7E769EBBEB25Q53551713-491ECF9A-A7CA-48E1-B7FE-A81F91AEA36BQ57427306-9AEE3D60-C046-4B10-AF73-8DA91EE2837CQ58242956-9CDF812F-4508-4E23-85BE-E3AD77657F25
P2860
A comparative analysis of generics markets in five European countries
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
A comparative analysis of generics markets in five European countries
@en
A comparative analysis of generics markets in five European countries
@nl
type
label
A comparative analysis of generics markets in five European countries
@en
A comparative analysis of generics markets in five European countries
@nl
prefLabel
A comparative analysis of generics markets in five European countries
@en
A comparative analysis of generics markets in five European countries
@nl
P1433
P1476
A comparative analysis of generics markets in five European countries
@en
P2093
L Garattini
P304
P356
10.1016/S0168-8510(00)00061-0
P577
2000-04-01T00:00:00Z